Management of transitional cell carcinoma by targeting the epidermal growth factor receptor

Author： Brook Nicholas R   Colquhoun Alex J   Mellon J Kilian  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.3, 2006-05, pp. : 407-416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 18, 2015-09 ,pp. : 4560-4574

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 1, 2012-01 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of Vascular Endothelial Growth Factor, Receptor KDR and p53 Protein in Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 81, Iss. 1, 2008-07 ,pp. : 72-76

Karger

Access to resources Recommend Favorite

Preanalytic parameters in epidermal growth factor receptor mutation testing for non–small cell lung carcinoma: A review of cytologic series

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 11, 2015-11 ,pp. : 633-643

John Wiley & Sons Inc

Access to resources Recommend Favorite